Mouse models of human genetic disease: Which mouse is more like a man?

BioEssays

Volumn 18, Issue 12, 1996, Pages 993-998

  Erickson, Robert P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030460933     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950181209     Document Type: Review

References (58)

1. Melton, D.W. (1994). Gene targeting in the mouse. BioEssays 16, 633-637.
2. Darling, S.M. and Abbott, C.M. (1992). Mouse models of human gene disorders. BioEssays 14, 359-366.
3. Smithies, O. (1993). Animal models of human genetic diseases. Trends Genet. 9, 112-116.
4. Searle, A.G., Edwards, J.H. and Hall, J.G. (1994). Mouse homologues of human hereditary disease. J. Med. Genet. 31, 1-19.
5. Games, D. et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
6. Erickson, R.P. (1989) Why isn't a mouse more like a man? Trends Genet. 5, 1-3.
7. Teicher, L.S. and Caspari, E. W. (1978) The genetics of blind - a lethal factor in mice. J. Hered. 69, 86-9 0.
8. Erickson, R.P. (1973). Erythrocytic nicotinamide-adenine dinucleotide phosphate levels and the genetic regulation of erythrocytic glucose 6-phosphate dehydrogenase activity in the inbred mouse. Biochem. Genet. 11, 33-4 0.
9. Erickson, R.P. (1990). Invited Editorial: Mapping dysmorphic syndromes with the aid of the human/mouse homology map. Am. J. Hum. Genet. 46, 1013-101 6.
10. Epstein, D. J., Vekemans, M. and Gros, P. (1991). Splotch (sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodamain of PAX-3. Cell 67, 767-77 4.
11. Tassabehji, M. et al. (1995). The mutational spectrum in Waardenburg syndrome. Hum. Mol. Genet. 4, 2131-213 7.
12. Hughes, A.E., Newton, V.E., Liu, X.Z. and Read, A.P. (1994). A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nature Genet. 7, 509-51 2.
13. Reynolds, J.E. et al. (1995). Major locus and polygenic contributions to variability of dystopia canthorum in Waardenburg syndrome. Am. J. Hum. Genet. 58, 384-39 2.
14. Asher, J.H., Jr., Harrison, R.W., Morell, R., Carey, M.L. and Friedman, T.B. (1994). Effects of Pax3 modifier genes on craniofacial morphology, pigmentation and viability: A murine model of Waardenburg Syndrome variation. Genomics 34, 285-29 8.
15. Zhang, Y., Proenca, R., Maffei M., Barone, M., Leopold, L. and Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-43 2.
16. Friedman, J.M., Leibel, R.L., Siegel, D.S., Welsh, J. and Bahary, N. (1991). Molecular mapping of the mouse ob mutation. Genomics 11, 1054-106 2.
17. Chen, H. et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491-49 5.
18. Todd, J.A. (1995). Genetic analysis of type 1 diabetes using whole genome approaches. Proc. Natl Acad. Sci. USA 92, 8560-8565.
19. Essien, F.B., Haviland, M.B. and Naidoff, A.E. (1990). Expression of a new mutation (Axd) causing axial defects in mice correlates with maternal phenotype and age. Teratology 42, 183-194.
20. Embury, S., Seller, M.J., Adinolfi, M. and Polani, P.E. (1979) Neural tube defects in curly-tail mice. I. Incidence, expression and similarity to the human condition. Proc. Roy. Soc. B. 206, 85-94.
21. Neumann, P.E., Frankel, W.N., Letts, V.A., Coffin, J.M., Copp, A.J. and Bernfield, M. (1994). Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nature Genet. 6, 357-362.
22. Moser, A.R., Pitot, H.C. and Dove, W.F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324.
23. Su, L.K. et al. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670.
24. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad. Sci. USA 90, 8977-8981.
25. Dietrich, W.F. et al. (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
26. Min-induced intestinal neoplasia. Cell 81, 957-966.
27. Leppert, M. et al. (1990). Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. New Engl. J. Med. 322, 904-908.
28. Baribault, H., Penner, J., Iozzo, R.V. and Wilson-Heiner, M. (1994). Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8, 2964-2973.
29. Threadgill, D.W. et al. (1995). Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science 269, 230-233.
30. Sibilia, M. and Wagner, E.F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238.
31. Sing, C.F., Risser, D.R., Howatt, W.F. and Erickson, R.P. (1982). Phenotypic heterogeneity in cystic fibrosis. Am. J. Med. Genet. 13, 179-195.
32. Castaldo, G. et al. (1996). Clinical features of cystic fibrosis patients with rare genotypes. J. Med. Genet. 33, 73-76.
33. Dorin, J.R. et al. (1994). Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type cftr gene expression. Mammal. Genome 5, 465-472.
34. Colledge, W.H. et al. (1995). Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nature Genet. 10, 445-452.
35. Zeiher, B.G. et al. (1995). A mouse model for the ΔF508 allele of cystic fibrosis. J. Clin. Invest. 96, 2051-2064.
36. Rozmahel, R. et al. (1996). Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12, 280-287.
37. Sweet, A., Erickson, R.P., Huntington, C. and Dawson, D. (1992). A potential animal model for studying CF heterozygote advantage: Genetic variation in theophylline-inducible colonic chloride currents among inbred strains of mice. Biochem. Med. Met. Biol. 47, 97-102.
38. Marotti, K.R., Castle, C.K., Boyle, T.P., Lin, A.H., Murray, R.W. and Melchior, G.W. (1993). Severe atherosclerosis in transgenic mice expressing simian cholestetyl ester transfer protein. Nature 364, 73-75.
39. Lawn, R.M., Wade, D.P., Hammer, R.E., Chiesa, G., Verstuyft, J.G. and Rubin, E.M. (1992). Atherogenesis in transgenic mice expressing human apolipoprotein (a). Nature 360, 531-632.
40. Zhang, S.H., Reddick, R.L., Piedrahita, J.A. and Maeda, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471.
41. Ishibashi, S., Brown, M.S., Goldstein, J.L., Gerard, R.D., Hammer, R.E. and Herz, J. (1993). Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893.
42. Homanics, G.E., Smith, T.J., Zhang, S.H., Lee, D., Young, S.G. and Maeda, N. (1993). Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc. Natl Acad. Sci. USA 90, 2389-2393.
43. Farese, R.V. Jr., Ruland, S.L., Flynn, L.M., Stokowski, R.P. and Young, S.G. (1995). Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl Acad. Sci. USA 92, 1774-1778.
44. Rubin, E.M., Krauss, R.M., Spangler, E.A., Verstuyft, J.G. and Clift, S.M. (1991). Inhibition of early atherogenesis in transgenic mice by human apolipoprotein Al. Nature 353, 265-267.
45. Warden, C.H., Hedrick, C.C., Quia, J.H., Castellani, L.W. and Lusis A.J. (1993). Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261, 469-472.
46. Paigen, B., Ishida, B.Y., Verstuyft, J., Winters, R.B. and Albee, D. (1990). Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Atherosclerosis 10, 316-323.
47. Paigen, B. (1995). Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am. J. Clin. Nut. 62, 458S-462S.
48. Lane, P.W. and Liu, H.M. (1984). Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J. Hered. 75, 435-439.
49. Donis-Keller, H. et al. (1993). Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum. Mol. Genet. 2, 851-856.
50. Puffenberger, E.G. et al. (1994). A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79, 1257-1266.
51. Puffenberger, E.G. et al. (1994). Identity-by-descent and association mapping of a recessive gene for Hirschsprung's disease in human chromosome 13q22. Hum. Mol. Genet. 3, 1217-1225.
52. Pavan, W. J., Mac, S., Cheng, M. and Tilghman, S.M. (1995). Quantitative trait loci that modify the severity of spotting in piebald mice. Genome Research 5, 29-41.
53. Wolgemuth, D.J., Behringer, R.R., Mostoller, M.P., Brinster, R.L. and Palmlter, R.D. (1989). Transgenic mice overexpressing the mouse homoeobox-containing gene Hox-1.4 exhibit abnormal gut development. Nature 337, 464-467.
54. Bertina, R.M. et al. (1994). Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
55. Nichols, W.C. et al. (1996). Moderation of hemophilia A phenotype by the factor VR506Q mutation. Blood (in press).
56. Wilkins, A.S. (1990). Position effects, methylation and inherited epigenetic states. BioEssays 12, 385-386.
57. Kaufman, S.A. (1993). The Origins of Order, p. 252. Oxford University Press, New York.
58. Wu, C.L. and Melton, D.W. (1993). Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nature Genet. 3, 235-240.